Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
ROCKET PHARMACEUTICALS, INC. (RCKT)
Sector: Healthcare; Industry: Biotechnology

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It also has additional infantile malignant osteopetrosis, a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption. In addition, the company has an adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. Rocket Pharmaceuticals, Inc. is headquartered in New York, New York.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-06-17 Makker Gotham Director Sell 35,085 $46.85 $1,643,693 No
2020-12-28 Patel Kinnari Chief Operating Officer Sell 16,761 $56.72 $950,745 No
2020-12-10 RTW INVESTMENTS, LP 10%-Owner, Director Buy 247,720 $56.00 $13,872,320 No
2020-03-18 Patel Kinnari Chief Operating Officer Buy 1,000 $9.50 $9,500 No
2019-12-10 RTW INVESTMENTS, LP 10%-Owner, Director Buy 225,000 $22.25 $5,006,250 No
2019-04-16 RTW INVESTMENTS, LP 10%-Owner, Director Buy 550,005 $17.50 $9,625,088 No
2019-03-05 Shah Gaurav See Remarks Sell 74,900 $17.17 $1,286,272 No
2018-12-13 SOUTHWELL DAVID P Director Sell 38,768 $15.19 $588,886 No
2018-12-07 SOUTHWELL DAVID P Director Sell 57,732 $15.13 $873,458 Yes
2018-12-06 Patel Kinnari Chief Operating Officer Buy 5,675 $14.98 $85,012 No
2018-08-01 Yalamanchi Naveen Director Sell 637 $22.00 $14,014 No
2017-01-06 SOUTHWELL DAVID P President and CEO Buy 60,000 $1.75 $105,000 No
2016-05-13 CARROLL J MARTIN Director Buy 10,000 $9.03 $90,294 No
2015-02-23 Pitango Venture Capital Principals Fund IV, L.P. 10%-Owner Buy 212,375 $6.00 $1,274,250 Yes
2015-02-23 KARABELAS ARGERIS N 10%-Owner, Director Buy 603,832 $6.00 $3,622,992 Yes
2015-02-23 CARE CAPITAL II LLC 10%-Owner Buy 603,832 $6.00 $3,622,992 Yes
2015-02-23 RHO VENTURES IV QP LP 10%-Owner Buy 958,226 $6.00 $5,749,356 Yes
2015-02-23 Kantesaria Devang 10%-Owner Buy 814,166 $6.00 $4,884,996 Yes
2015-02-23 DEVON PARK BIOVENTURES LP 10%-Owner Buy 814,166 $6.00 $4,884,996 Yes
2015-02-23 MedImmune Ventures, Inc. 10%-Owner Buy 416,667 $6.00 $2,500,002 Yes

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.